AGM Point Form ReportPOINT FORM AGM REPORT
OK guy’s / Gal’s… this is my first time doing this so herewe go !!!
First of all, I found the presentationexcellent and extremely professional.
I hope that a copy of their presentations will be on thePharmagap website soon as it was good.
The following is what was said.
-5 Directors were all re-elected for another year, plus anotherwas added - Mr Ian Malone has joint them. They now have six.
-It was discussed that they would be looking at maybeadding another one next quarter depending on how progress are made. They arehowever not taking this lightly and would add one more (bringing the total to7) only after carefully revising the benefit that would help the Company.
As you all know Licensing deal is sought, however they arenot ready to make a deal just for the sake of making a deal, their strategy isto build a good case with positive results so that Big Pharma will want in at afair Value for the Company and Shareholders. So I would not expect a Licensingdeal just yet.
So it did not give us the feeling that a deal was about tobe struck…. But Big-Pharma are looking at us that is for sure.
-More NR’s are to come from now to end of July and itgave me the impression that they are expecting good results from those teststoo.
They also emphasized that GAP is not only about theirleading cancer drug but that GAP is also about the Proprietary Methodology thatthey use and that this Methodology could also be used for additional drug /additional Therapy.
Company is now approx 21 Millions Value = Undervalued fromtheir estimations.
They are planning tospend 2.5 – 3.0 Mil in the next 12 – 18 Months
Keep on building on existing relationships with Big Pharmaand create new one.
June 2012 – It the target date for Phase 1 Trial.
If I missed something and you were also there please feelfree to add or correct what I have said.
Thanks and GLTA